Laddar...
One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™
BACKGROUND: Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW™ COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has...
Sparad:
| I publikationen: | J Clin Virol |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
The Authors. Published by Elsevier B.V.
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8196482/ https://ncbi.nlm.nih.gov/pubmed/34174710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2021.104896 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|